Hanna GJ, Kofman ER, Shazib MA, et al. Integrated genomic characterization of oral carcinomas in post-hematopoietic stem cell transplantation survivors. Oral Oncol. 2018;81:1-9. doi:10.1016/j.oraloncology.2018.04.007
Yu M, Maden SK, Stachler M, et al. Subtypes of Barrett’s oesophagus and oesophageal adenocarcinoma based on genome-wide methylation analysis. Gut. 2019;68(3):389-399. doi:10.1136/gutjnl-2017-314544
Genereux DP, Laird CD. At what rate do new premutation alleles arise at the fragile X locus? Hum Genet. 2013;132(6):715-7. doi:10.1007/s00439-013-1291-6
Renneville A, Boissel N, Nibourel O, et al. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association. Leukemia. 2012;26(6):1247-54. doi:10.1038/leu.2011.382
Guo L, Kim HJ, Wang H, et al. Nuclear-Import Receptors Reverse Aberrant Phase Transitions of RNA-Binding Proteins with Prion-like Domains. Cell. 2018;173(3):677-692.e20. doi:10.1016/j.cell.2018.03.002
Redmond SN, MacInnis BM, Bopp S, et al. De Novo Mutations Resolve Disease Transmission Pathways in Clonal Malaria. Mol Biol Evol. 2018;35(7):1678-1689. doi:10.1093/molbev/msy059
Klein HU, De Jager PL. How do we measure the epigenome(s)? Mult Scler. 2018;24(4):446-448. doi:10.1177/1352458517750772
Oates EC, Jones KJ, Donkervoort S, et al. Congenital Titinopathy: Comprehensive characterization and pathogenic insights. Ann Neurol. 2018;83(6):1105-1124. doi:10.1002/ana.25241
Cho SW, Xu J, Sun R, et al. Promoter of lncRNA Gene PVT1 Is a Tumor-Suppressor DNA Boundary Element. Cell. 2018;173(6):1398-1412.e22. doi:10.1016/j.cell.2018.03.068
Hayden MA, Ordulu Z, Gallagher S, et al. Clinical, pathologic, cytogenetic, and molecular profiling in self-identified black women with uterine leiomyomata. Cancer Genet. 2018;222-223:1-8. doi:10.1016/j.cancergen.2018.01.001